Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
This study was conducted to evaluate the relationship between antimicrobial resistance and antimicrobial use in a university hospital in Taiwan. Disk susceptibility data of Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp., Stenotrophomonas maltophilia and other non-fermentative Gram-negative bacilli causing nosocomial infections were evaluated. Data on annual patient-days and annual consumption (defined daily dose (DDD) per 1000 patient-days) of extended-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, flumoxef, cefepime and cefpirome), β-lactam–β-lactamase inhibitor combinations (ticarcillin/clavulanic acid and piperacillin/tazobactam), carbapenems (imipenem and meropenem), aminoglycosides (amikacin, gentamicin and tobramycin), fluoroquinolones (ciprofloxacin (oral and injectable) and oral levofloxacin and moxifloxacin) from 1991 to 2003 were analysed. Increasing trends of incidences of several of these bacteria causing all nosocomial infections or nosocomial bloodstream infections were noted from 1991 to 2003. The annual patient-days of the hospital significantly increased, from 360 210 in 1991 to 672 676 in 2002 (linear regression analysis, P < 0.05), but slightly decreased in 2003 (629 168) owing to the severe acute respiratory syndrome epidemic in Taiwan. The rise in cefotaxime-resistant or ciprofloxacin-resistant E. coli and meropenem-resistant P. aeruginosa was significantly correlated with increased consumption of extended-spectrum cephalosporins, β-lactam–β-lactamase inhibitor combinations, carbapenems, fluoroquinolones and aminoglycosides (for ciprofloxacin-resistant E. coli and meropenem-resistant P. aeruginosa only) in the hospital (Pearson's correlation coefficient, r > 0.72 (or <−0.72) and P-value < 0.05). Increased ciprofloxacin-resistant K. pneumoniae and meropenem-resistant Acinetobacter spp. was significantly associated with the increased usage of extended-spectrum cephalosporins but not with the other four classes of antibiotics. This 13-year study in a hospital demonstrated significant changes in antimicrobial use, which may have affected antimicrobial resistance in certain Gram-negative bacteria at the hospital.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F., & Gaynes, R. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.211 · Cited by 436
Rice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.118 · Cited by 313
Fish, D. N., Piscitelli, S. C., & Danziger, L. H. (1995) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04366.x · Cited by 178
Fluit, A. C., Schmitz, F., & Verhoef, J. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100455 · Cited by 167
Hsueh, P.-R., Chen, M.-L., Sun, C.-C., Chen, W.-H., Pan, H.-J., Yang, L.-S., Chang, S.-C., Ho, S.-W., Lee, C.-Y., Hsieh, W.-C., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0801.000454 · Cited by 162
Self-citationKarlowsky, J. A., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1672-1680.2003 · Cited by 135
Flamm, R. K., Weaver, M. K., Thornsberry, C., Jones, M. E., Karlowsky, J. A., & Sahm, D. F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2431-2436.2004 · Cited by 121
Fluit, A. C., Verhoef, J., Schmitz, F., & Participants, T. E. S. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100564 · Cited by 115
Fridkin, S. K., Edwards, J. R., Tenover, F. C., Gaynes, R. P., McGowan, J. E., & Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project (2001) · Clinical Infectious Diseases · doi:10.1086/321893 · Cited by 115
Control of Nosocomial Antimicrobial-Resistant Bacteria: A Strategic Priority for Hospitals Worldwide
Goldmann, D. A., & Huskins, W. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s139 · Cited by 109
THE IMPACT OF ANTIMICROBIAL USE ON THE EMERGENCE OF ANTIMICROBIAL-RESISTANT BACTERIA IN HOSPITALS
Gaynes, R. P. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70388-3 · Cited by 102
Loeffler, J. M., Garbino, J., Lew, D., et al. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016646 · Cited by 84
Bantar, C., Vesco, E., Heft, C., Salamone, F., Krayeski, M., Gomez, H., Coassolo, M. A., Fiorillo, A., Franco, D., Arango, C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.392-395.2004 · Cited by 58
Ray, G. T., Baxter, R. P., & DeLorenze, G. N. (2005) · Clinical Infectious Diseases · doi:10.1086/431980 · Cited by 45
Cited by
The growing burden of antimicrobial resistance
Hawkey, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn241 · Cited by 377
Emergence and spread of antibiotic resistance following exposure to antibiotics
Cantón, R., & Morosini, M.-I. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00295.x · Cited by 351
Yang, P., Chen, Y., Jiang, S., Shen, P., Lu, X., & Xiao, Y. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03856-1 · Cited by 14
“The correlation of the rate of 3GCresistant E. coli and extended-spectrum cephalosporins consumption was demonstrated by a university hospital in Taiwan [16].”
Background
Metadata
- Authors
- Hsueh, P.-R., Chen, W.-H., & Luh, K.-T.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 26
- Issue
- 6
- Pages
- 463-472
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2093115743
- Cited by
- 262
- References
- 20
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.